Researchers create antibodies against the SARS-CoV-2 from hen eggs

Scientists at the University of California, Davis, have created antibodies against the SARS-CoV-2 spike protein in hen eggs. Egg-derived antibodies may be used to treat COVID-19 or as a prophylactic step for those who have been exposed to the illness. The article appeared in the journal Viruses on July 9th, 2022.

Researchers create antibodies against the SARS-CoV-2 from hen eggs
Birds produce a form of antibody, IgY, found in eggs. UC Davis researchers have shown that quantities of IgY antibody specific for the COVID-19 virus spike protein can be produced from eggs by immunizing hens. Image Credit: Getty Images

The beauty of the system is that you can produce a lot of antibodies in birds. In addition to a low cost to produce these antibodies in hens, they can be updated very fast by using updated antigens to hyperimmunize hens, allowing protection against current variant strains.”

Rodrigo Gallardo, Professor, Poultry Medicine, Population Health and Reproduction, UC Davis School Of Veterinary Medicine

IgY, a kind of antibody that is similar to IgG in humans and other mammals, is produced by birds. When administered to people, IgY does not produce allergy symptoms or trigger immunological responses. IgY can be found in the serum and eggs of birds. A person can consume a lot of IgY, according to Gallardo, as a hen produces roughly 300 eggs every year.

Using three distinct vaccines depending on the SARS-CoV-2 spike protein or receptor binding domain, Gallardo and associates immunized chickens twice. Three and six weeks following the previous vaccine, the antibodies in hen blood samples and egg yolks were assessed.

The National Center for Biodefense and Infectious Diseases at George Mason University in Virginia investigated purified antibodies to see if they could prevent coronavirus from attacking human cells.

Vaccinated hens’ eggs and sera both contained SARS-CoV-2-recognizing antibodies. Since there are more antibodies in blood generally, according to Gallardo, serum antibodies were more powerful at neutralizing the virus.

To create the egg-based antibody technology, Gallardo is collaborating with partners Daria Mochly-Rosen at Stanford University and Michael Wallach at the University of Technology, Sydney. The team wants to put these antibodies in a spray or other prophylactic medication that those who are at high risk of coronavirus contact might take.

Source:
Journal reference:

Aston, E. J., et al. (2022) Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2. Viruses. doi.org/10.3390/v14071510.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The University of California, Davis. (2022, November 15). Researchers create antibodies against the SARS-CoV-2 from hen eggs. AZoLifeSciences. Retrieved on November 30, 2022 from https://www.azolifesciences.com/news/20220714/Researchers-create-antibodies-against-the-SARS-CoV-2-from-hen-eggs.aspx.

  • MLA

    The University of California, Davis. "Researchers create antibodies against the SARS-CoV-2 from hen eggs". AZoLifeSciences. 30 November 2022. <https://www.azolifesciences.com/news/20220714/Researchers-create-antibodies-against-the-SARS-CoV-2-from-hen-eggs.aspx>.

  • Chicago

    The University of California, Davis. "Researchers create antibodies against the SARS-CoV-2 from hen eggs". AZoLifeSciences. https://www.azolifesciences.com/news/20220714/Researchers-create-antibodies-against-the-SARS-CoV-2-from-hen-eggs.aspx. (accessed November 30, 2022).

  • Harvard

    The University of California, Davis. 2022. Researchers create antibodies against the SARS-CoV-2 from hen eggs. AZoLifeSciences, viewed 30 November 2022, https://www.azolifesciences.com/news/20220714/Researchers-create-antibodies-against-the-SARS-CoV-2-from-hen-eggs.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post
You might also like...
UC Davis launches new center to accelerate the development of promising cancer therapies